Chester, England (ots/PRNewswire)
- Accepts Prestigious 2004 'Investors in People' Award
Wolters Kluwer Health, Pharma Solutions business unit today
announced that Adis International was named a 2004 "Investor in
People" by the Investors in People UK Recognition Panel. The
London-based organization assesses corporate business practices
against a national standard and recognizes only those companies that
meet or exceed those requirements.
The Adis offices in Chester, Oxford and London were recognized for
a superior commitment to supporting the development of its people. A
full-scale assessment, which included interviews with 31 employees,
determined that the company had moved forward, improved methods of
communication and forged a "very positive attitude and atmosphere
"The development of our people is of paramount importance to us,"
said Peter George, EVP of Europe and Asia Pacific. "It is also
completely in line with our business objective to always strive for
improvement. To be a guiding force tomorrow, we must invest in our
"Investors in People" is a national standard that sets out a level
of good practice for training and development of people to achieve
business goals. The standard provides a national framework for
improving business performance and competitiveness, through a planned
approach to setting and communicating business objectives and
developing people to meet these objectives.
The Investors in People (UK) program was established in 1993 to
provide national ownership of the Investors in People Standard and is
responsible for its promotion and branding, quality assurance and
development. Since 1991, tens of thousands of UK employers have
become involved with the standard.
As part of Wolters Kluwer Health, Pharma Solutions business unit,
Adis International is one of the preeminent information providers to
the pharmaceutical and biotechnology markets. Adis journals are among
the most-cited publications in their respective fields, and provide a
unique blend of original articles, authoritative reviews, profiles,
and drug evaluations.
For more information about the Investors in People program, visit
. For more about Adis and Wolters Kluwer
Health, Pharma Solutions, visit http://www.wkhealth.com
About Wolters Kluwer Health
The Wolters Kluwer Health Pharma Solutions division provides
information and communications support for the pharmaceutical
industry, from drug discovery and research to launch and marketing
under the industry's leading medical information brands, Adis
International, IFI Claims and Lippincott Williams & Wilkins.
Wolters Kluwer Health is a unit of WoltersKluwer nv, a leading
multinational publisher and information services company with annual
revenues (2003) of euro 3.4 billion and employing approximately
18,750 people worldwide. Wolters Kluwer is headquartered in
Amsterdam, the Netherlands. Its depositary receipts of shares are
quoted on the Euronext Amsterdam (WKL) and are included in the AEX
and Euronext 100 indices.
For more information, visit http://www.adis.com
Contact: Tom Kivett
Kivett & Company Communications
Web site: http://www.wkhealth.com
ots Originaltext: Wolters Kluwer Health, Pharma Solutions
Im Internet recherchierbar: http://www.newsaktuell.ch
Tom Kivett of Kivett & Company Communications, +1-212-727-2935,
, for Wolters Kluwer Health, Pharma Solutions